Bayer AG (XTER:BAYN)
€ 24.08 -0.285 (-1.17%) Market Cap: 23.66 Bil Enterprise Value: 55.94 Bil PE Ratio: 0 PB Ratio: 0.66 GF Score: 67/100

Bayer AG Crop Science R&D Pipeline Update Call Transcript

Feb 13, 2020 / 01:00PM GMT
Release Date Price: €77.3 (-0.46%)
Operator

Ladies and gentlemen, thank you for standing by. Welcome to Bayer's Crop Science R&D Pipeline Update. (Operator Instructions) I would now like to turn the conference over to Mr. Oliver Maier, Head of Investor Relations of Bayer AG. Please go ahead, sir.

O. Maier
Bayer Aktiengesellschaft - Head of IR

Thank you very much, Emma. Good morning, and welcome to those joining us on the call today. We very much appreciate you joining us. We know it's a busy day today. We are very excited to be with you and share our annual research and development pipeline update for the Bayer Crop Science. As leaders in the space, we look forward to providing this update every year, not only for the benefit of our owners, but to provide transparency on the innovation we are bringing to our growers, customers and other stakeholders.

With me on the call today are Liam Condon, the President of Crop Science -- of the Crop Science Divisions; Bob Reiter, who leads R&D for Crop Science and several members of his leadership team, including Mike Graham, Head of Breeding

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot